A U.S. based leading pharmaceutical company approached Freyr for assistance in filing original IND application along with its amendments to the USFDA. The client was facing challenges, as there were a large volume of Module 4 and 5 documents to be addressed in a short span of time. Freyr assisted the client with end-to-end publishing activities by adhering to the timelines.

Read the case study to know about Freyr’s approach of dealing with IND applications with zero deficiency.